United Kingdom

Man and woman embracing

Prostate cancer surgery breakthrough offers hope for erectile function

A new form of prostate cancer surgery nearly doubles the chances of men retaining erectile function, according to a new trial conducted by University College London. Known as NeuroSafe, the procedure checks tissue removed during the operation. If the tumor appears to have been removed, the nerve-containing outer layer of the prostate is left intact. The trial assessed 344 men with prostate cancer and no history of erectile dysfunction. 56% of men who had standard surgery reported severe erectile dysfunction, compared with 38% who had NeuroSafe surgery.

Big Ben

U.K. emissions fall to lowest level since 1872

In a major win for climate action, a new analysis from Carbon Brief has found that the country’s planet-warming emissions fell by 3.6% to 371 million tons of carbon dioxide equivalent in 2024, the lowest since Queen Victoria’s reign. Last year’s decrease was largely driven by a drop in coal use, led by the closure of the UK’s last coal-fired power station and one of its last blast furnaces. Other contributors included a drop in demand for oil and gas and a nearly 40% rise in electric vehicles on the road.

Empty office desk and chairs

Two hundred U.K. companies sign up for permanent four-day working week

Two hundred U.K. companies have signed up for a permanent four-day working week for all their employees with no loss of pay, in the latest landmark in the campaign to reinvent Britain’s working week. Together, the companies employ more than 5,000 people, with charities, marketing, and technology firms among the best-represented. Supporters say the four-day week is a useful way of attracting and retaining employees while improving productivity by creating the same output over fewer hours and fostering a more fulfilled, happy, and engaged workforce.

Good news for British climate action

Renewable power set to overtake fossil fuels in the U.K. this year for the first time

While particularly windy periods have meant certain days in the last few years have been dominated by renewable power as turbines lit up the grid, this is the first time through an entire calendar year that renewable energy will be greater than power generated from burning oil, gas and coal. The shift is driven largely by a decline in production from coal, gas, and oil, as well as growing wind, solar, and biomass power, according to think tank Ember.

sidharth bhatia QstzxTWnXY unsplash scaled e

77% of universities have now pledged to divest from fossil fuels

115 U.K. universities have now pledged to exclude fossil fuel companies from their investment portfolios, following Birmingham City University, Glasgow School of Art, Royal Northern College of Music, and the University of Bradford all incorporating fossil fuel industry exclusions into their Ethical Investment Policies. The divested universities represent 77% of the U.K. Higher Education sector and more than $22 billion USD worth of endowments.

Model lungs

Doctors hail first breakthrough in asthma and COPD treatment in 50 years

A trial from King’s College London found offering patients a new injection was more effective than the current care of steroid tablets, and cuts the need for further treatment by 30%. The results, published in the Lancet Respiratory Medicine journal, could be transformative for millions of people with asthma and COPD around the world. Lead investigator Professor Mona Bafadhel said: “This could be a gamechanger for people with asthma and COPD. Treatment for asthma and COPD exacerbations have not changed in 50 years, despite causing 3.8 million deaths worldwide a year combined.”

Ovarian and Cervical Cancer Awareness. a Teal Ribbon

New cervical cancer treatment regime ‘cuts risk of dying from disease by 40%’

Doctors are hailing a “remarkable” new treatment regime for cervical cancer developed by researchers at University College London that reduces the risk of dying by 40%, in the biggest advance against the disease in 25 years. The new treatment plan was tested in patients recruited over 10 years from the UK, Mexico, India, Italy, and Brazil. Cervical cancer is the fourth most common cancer in women globally, with about 660,000 new cases and 350,000 deaths every year, according to the World Health Organization.

Scientists in the U.K. developing world’s first vaccine to prevent ovarian cancer

Researchers at the University of Oxford are working on the world’s first ovarian cancer vaccine, aiming to prevent the disease that kills nearly 26,000 women in the European Union every year. The vaccine, called OvarianVax, would train the immune system to recognize and fight back against the earliest stages of ovarian cancer, one of the most common forms of cancer among women which often isn’t detected until a later stage when it’s harder to treat. Cancer Research U.K. will fund the OvarianVax research with up to £600,000 for the effort.

Model lungs

World-first lung cancer vaccine trials launched across seven countries

Lung cancer is the world’s leading cause of cancer death, accounting for about 1.8 million deaths every year. Now experts are testing a new jab that instructs the body to hunt down and kill cancer cells – then prevents them from ever coming back. Known as BNT116 and made by BioNTech, the vaccine is designed to treat non-small cell lung cancer, the most common form of the disease. The phase 1 clinical trial, the first human study of BNT116, has launched across 34 research sites in seven countries: the U.K., U.S., Germany, Hungary, Poland, Spain, and Turkey.